University of Leicester |

Home >> News and Events >> [eBulletin] >> News


University of Leicester student receives bursary from scheme to support chemistry education in the UK

[AstraZeneca media release, February 2003]

A University of Leicester student, Stephen Gray (pictured with Dave Lathbury, Head of Process Chemistry, AstraZeneca, Loughborough (left) and Professor Jonathan Percy, Department of Chemistry, University of Leicester) is one of fifty first-year students to be awarded bursaries as part of a scheme by AstraZeneca to support chemistry education. Currently on an MChem Chemistry degree course at the University of Leicester, Stephen has received the bursary based on his excellent A-level scores. [Photo: Stephen Gray, bursary winner, with University staff]

AstraZeneca, one of the world’s leading pharmaceutical companies with a research and development site in Loughborough is awarding top performing students in the UK £1,000 a year for the length of their four-year Chemistry course. The scheme, which started in March 2002, has had such a good response that AstraZeneca is offering further bursaries for students looking to start Chemistry studies in autumn 2003 and beyond. 

The bursaries are part of a long-term programme by AstraZeneca to support chemistry education and Leicester is one of 23 universities operating the scheme. 50 awards totalling £200,000 over the four year period are being made this year.
Jonathan Percy, Professor of Organic Chemistry at the University of Leicester, said "The AstraZeneca Bursary scheme tells us that one of the leading pharmaceutical companies recognises the great value of highly-qualified 'A' level students to UK chemistry. By rewarding student performance the bursary scheme sends out a very positive message to prospective students considering Chemistry”. 
Under the scheme students opting to obtain work experience as part of their studies are being offered the opportunity to work at AstraZeneca, where they will be paid a salary in place of the bursary for that time period. The students can also visit one of AstraZeneca’s research sites in the UK, as well as be given preferential consideration for work placement opportunities within the company upon graduation.

Back to News
Back to [eBulletin] index

[University Home][University Index A-Z][University Search][University Help]

Last updated: 4 March 2003 10:50
Maintained by: Barbara Whiteman

This document has been approved by the head of department or section.
If you are an authorised user you may edit this document through your Web browser.